Novavax logo

Novavax Share Price (NASDAQ: NVAX)

$8.98

-0.54

(-5.67%)

Live

Last updated on

Check the interactive Novavax Stock chart to analyse performance

Novavax stock performance

as on August 20, 2025 at 11:37 PM IST

  • Today's Low:$8.70
    Today's High:$9.20

    Day's Volatility :5.44%

  • 52 Weeks Low:$5.01
    52 Weeks High:$15.22

    52 Weeks Volatility :67.08%

Novavax Stock Returns

PeriodNovavax, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
33.83%
1.5%
0.0%
6 Months
18.64%
-7.1%
0.0%
1 Year
-26.92%
-11.4%
0.0%
3 Years
-73.17%
2.9%
-9.6%

Novavax, Inc. Key Stats

Check Novavax key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$9.52
Open
$9.63
Today's High
$9.195
Today's Low
$8.695
Market Capitalization
$1.5B
Today's Volume
$4.4M
52 Week High
$15.22
52 Week Low
$5.01
Revenue TTM
$1.1B
EBITDA
$407.5M
Earnings Per Share (EPS)
$2.22
PE Ratio
4.29
Profit Margin
39.2%
Quarterly Earnings Growth YOY
-0.38%
Return On Equity TTM
-898.2%

Stock Returns calculator for Novavax Stock including INR - Dollar returns

The Novavax stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Novavax investment value today

Current value as on today

₹72,860

Returns

₹27,140

(-27.14%)

Returns from Novavax Stock

₹31,029 (-31.03%)

Dollar Returns*

₹3,889 (+3.89%)

Indian investors sentiment towards Novavax Stock

95.35%

Period: Jul 20, 2025 to Aug 19, 2025. Change in 30 Days versus previous period

Investment in Novavax Shares from India has grown by 95.35% over the past 30 days, indicating increased transactional activity.

22%

Period: Jul 20, 2025 to Aug 19, 2025. Change in 30 Days versus previous period

Search interest for Novavax Stock from India on INDmoney has increased by 22% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Novavax, Inc.

  • Name

    Holdings %

  • Vanguard Group Inc

    9.50%

  • BlackRock Inc

    7.98%

  • Shah Capital Management

    7.09%

  • State Street Corp

    4.33%

  • Sanofi

    4.24%

  • D. E. Shaw & Co LP

    2.43%

Analyst Recommendation on Novavax Stock

Rating
Trend

Buy

    66%Buy

    16%Hold

    16%Sell

Based on 12 Wall street analysts offering stock ratings for Novavax(by analysts ranked 0 to 5 stars)

Novavax Share Price Target

What analysts predicted

Upside of 46.36%

Target:

$13.14

Current:

$8.98

Novavax share price target is $13.14, a slight Upside of 46.36% compared to current price of $8.98 as per analysts' prediction.

Novavax Stock Insights

  • Price Movement

    In the last 7 days, NVAX stock has moved up by 7.5%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 666.65M → 239.24M (in $), with an average decrease of 64.1% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 518.64M → 106.50M (in $), with an average decrease of 79.5% per quarter
  • NVAX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 63.3% return, outperforming this stock by 90.2%
  • NVAX vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.3% return, outperforming this stock by 186.0%
  • Price to Sales

    ForNVAX every $1 of sales, investors are willing to pay $1.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $24.1 for every $1 of sales.

Novavax, Inc. Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$682.2M
↑ 22.61%
Net Income
$-187.5M
↓ 65.6%
Net Profit Margin
-27.49%
↑ 70.48%

Novavax Technicals Summary

Sell

Neutral

Buy

Novavax is currently in a neutral trading position according to technical analysis indicators.

Novavax, Inc. Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Novavax, Inc. logo
32.71%
18.64%
-26.92%
-73.17%
-93.09%
Regeneron Pharmaceuticals, Inc. logo
4.65%
-16.73%
-52.11%
-6.73%
-5.71%
Beone Medicines Ltd logo
7.16%
32.17%
61.08%
80.84%
30.07%
Vertex Pharmaceuticals Incorporated logo
-14.79%
-17.19%
-19.84%
32.96%
44.01%
Alnylam Pharmaceuticals, Inc. logo
43.03%
83.01%
63.29%
110.39%
235.62%

About Novavax, Inc.

Novavax, Inc. is a biotechnology company focused on delivering novel products that effectively use innovative technology to solve known and emerging disease threats. The biotechnology giant is dedicated to creating cost-effective and democratized vaccine solutions for infectious diseases, such as seasonal flu, Ebola, COVID-19, and more. Founded in 1987, Novavax, Inc. is headquartered in Gaithersburg, Maryland. It specializes in developing recombinant vaccines, and its lineup includes NVX-CoV2373, NanFlu, and ResVax, helpful in treating or preventing coronavirus, seasonal quadrivalent influenza, and a respiratory syncytial virus, respectively. Novavax, Inc. is also testing Matrix-M and its EBOV vaccine candidate in the Phase I clinical trial. It is also developing additional pre-clinical stage vaccine programs for occurrences such as MERS. It presently has over 750 employees, and its Nuvaxovid, a COVID-19 solution, is the fifth approved vaccine in the European Union. Further, Novavax has also filed the complete CMC data package with the FDA. It combines Novavax’s manufacturing prowess with Serum Institute of India Pvt. Ltd. (SII)’s experience for improved vaccine manufacturing. In addition, it also purchased Praha Vaccines and its vaccine factory in the Czech Republic, having a capacity of 1 billion doses per year. Currently Novavax, Inc. has a market cap of $1.83 Billion. It has a P.E ratio of -6.2. The shares of Novavax, Inc. are trading at $9.52. .
Organization
Novavax
Employees
952
CEO
Mr. John Charles Jacobs M.B.A.
Industry
Health Technology

Key Management of Novavax, Inc.

NameTitle
Mr. John Charles Jacobs M.B.A.
President, CEO & Director
Mr. James Patrick Kelly C.F.A.
Executive VP, CFO & Treasurer
Mr. Mark J. Casey Esq.
Executive VP, Chief Legal Officer & Corporate Secretary
Ms. Elaine O'Hara
Executive VP & Chief Strategy Officer
Mr. Richard P. Crowley
Executive VP & COO
Mr. Troy Morgan Esq., J.D.
Senior VP, Deputy General Counsel & Chief Compliance Officer
Ms. Erika S. Trahan
Associate Director of Investor & Public Relations
Mr. Ian J. Watkins
Executive VP & Chief Human Resources Officer
Ms. Silvia Taylor M.B.A.
Executive VP and Chief Corporate Affairs & Advocacy Officer
Dr. Henrietta Ukwu FACP FRAPS, M.D.
Executive VP & Chief Regulatory Officer

Important FAQs about investing in NVAX Stock from India :

What is Novavax share price today?

Novavax share price today is $8.98 as on . Novavax share today touched a day high of $9.20 and a low of $8.70.

What is the 52 week high and 52 week low for Novavax share?

Novavax share touched a 52 week high of $15.22 and a 52 week low of $5.01. Novavax stock price today i.e. is trending at $8.98, lower by 41% versus the 52 week high.

How to invest in Novavax Stock (NVAX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Novavax on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Novavax Shares that will get you 0.1670 shares as per Novavax share price of $8.98 per share as on August 20, 2025 at 11:37 PM IST.

What is the minimum amount required to buy Novavax Stock (NVAX) from India?

Indian investors can start investing in Novavax (NVAX) shares with as little as ₹87.0225 or $1 (as of August 20, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹870.22 in Novavax stock (as per the Rupee-Dollar exchange rate as on August 20, 2025). Based on Novavax share’s latest price of $8.98 as on August 20, 2025 at 11:37 PM IST, you will get 1.1136 shares of Novavax. Learn more about fractional shares .

What are the returns that Novavax has given to Indian investors in the last 5 years?

Novavax stock has given -93.09% share price returns and 16.26% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?